These findings support the pathologic and molecular heterogeneity of medulloblastoma [57], [58] and suggest that in addition to a role in the diagnosis of pineal and retinal tumors, CRX immunohistochemistry may provide critical information in determining subtype classification and poor prognosis in cases of medulloblastoma [59]. This evidence concerns the gene CRX and retina neoplasm.